Susquehanna International Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Hold
0
6762
2024
Q2
Sell
-11,087
Closed -$58.1K 6782
2024
Q1
$58.1K Sell
11,087
-37,509
-77% -$197K ﹤0.01% 5145
2023
Q4
$254K Buy
48,596
+5,856
+14% +$30.6K ﹤0.01% 4725
2023
Q3
$674K Sell
42,740
-14,266
-25% -$225K ﹤0.01% 3017
2023
Q2
$1.11M Sell
57,006
-16,394
-22% -$319K ﹤0.01% 2579
2023
Q1
$2.08M Buy
73,400
+54,449
+287% +$1.54M ﹤0.01% 1912
2022
Q4
$554K Buy
18,951
+47
+0.2% +$1.37K ﹤0.01% 3070
2022
Q3
$499K Buy
+18,904
New +$499K ﹤0.01% 3548
2022
Q2
Sell
-9,451
Closed -$468K 6852
2022
Q1
$468K Sell
9,451
-7,915
-46% -$392K ﹤0.01% 3806
2021
Q4
$884K Buy
17,366
+7,597
+78% +$387K ﹤0.01% 3016
2021
Q3
$545K Buy
9,769
+414
+4% +$23.1K ﹤0.01% 3573
2021
Q2
$400K Buy
9,355
+3,398
+57% +$145K ﹤0.01% 4157
2021
Q1
$249K Buy
+5,957
New +$249K ﹤0.01% 4567
2020
Q4
Sell
-6,372
Closed -$271K 5403
2020
Q3
$271K Buy
+6,372
New +$271K ﹤0.01% 3638
2020
Q2
Sell
-7,045
Closed -$324K 5091
2020
Q1
$324K Buy
+7,045
New +$324K ﹤0.01% 3347
2019
Q4
Sell
-9,317
Closed -$527K 4980
2019
Q3
$527K Sell
9,317
-6,586
-41% -$373K ﹤0.01% 2854
2019
Q2
$885K Buy
15,903
+5,930
+59% +$330K ﹤0.01% 2220
2019
Q1
$504K Sell
9,973
-11,674
-54% -$590K ﹤0.01% 1843
2018
Q4
$872K Buy
+21,647
New +$872K ﹤0.01% 1611
2018
Q3
Hold
0
4913
2018
Q2
Sell
-3,835
Closed -$202K 4905
2018
Q1
$202K Sell
3,835
-17,543
-82% -$924K ﹤0.01% 2824
2017
Q4
$1.14M Buy
+21,378
New +$1.14M ﹤0.01% 1651
2017
Q3
Hold
0
4391
2017
Q2
Hold
0
4514
2017
Q1
Hold
0
4576
2016
Q4
Hold
0
4881
2016
Q3
Hold
0
4129
2016
Q2
Hold
0
4220
2016
Q1
Sell
-33,053
Closed -$2.93M 4505
2015
Q4
$2.93M Buy
33,053
+1,255
+4% +$111K ﹤0.01% 1179
2015
Q3
$2.35M Buy
31,798
+18,820
+145% +$1.39M ﹤0.01% 1480
2015
Q2
$1.05M Sell
12,978
-16,764
-56% -$1.36M ﹤0.01% 2642
2015
Q1
$1.25M Buy
+29,742
New +$1.25M ﹤0.01% 2211